Furthermore, miR-324-3p can increase the production of lipid reactive oxygen species (ROS) by targeting glutathione peroxidase 4 (GPX4) in breast cancer cells, resulting in ferroptosis while preventing tumor cells from spreading distant [126], which offers a new potential target for the treatment of TNBC. Here, GPX4 is linked to breast carcinoma.